Explore › Finding
Finding improvement
Among 1,378 HIV-infected women enrolled during pregnancy, 38.3% met ART eligibility criteria (CD4 <200 or <350 with WHO stage III) during pregnancy, and this group had 23.7% mortality by 24 months in the pre-ART era, supporting urgent pregnancy-based ART screening to avoid SDNVP exposure entirely.
Effect size38.3%
Follow-up24 months
ComparatorNo screening during pregnancy (women identified as ART-eligible only after delivery)
Effect summaryimprovement; 38.3%

Connected entities

Interventions
HIV screening
Conditions
HIV infection
Outcomes
Proportion of uterus
Populations
Pregnant Women

Source

PMC2782481
Mortality and virologic outcomes following access to antiretroviral therapy among a cohort of HIV-infected women who received single-dose nevirapine in Lusaka, Zambia
Read on PMC → · View in graph →